Beijing [China], January 18 (ANI): Chinese scientists recently reported the key role of histone acetylation-regulated long noncoding RNA termed as lysosome cell death regulator (LCDR) in tumour survival, providing a potential diagnostic and therapeutic target for lung cancer.
Beijing [China], January 18 (ANI): Chinese scientists recently reported the key role of histone acetylation-regulated long noncoding RNA termed as lysosome cell death regulator (LCDR) in tumour survival, providing a potential diagnostic and therapeutic target for lung cancer.
\
\
